Tectorigenin inhibits inflammatory responses in murine inflammatory bowel disease and LPS‐stimulated macrophages via inactivating MAPK signaling pathway

Abstract Background Considering the antihepatitis effects of Tectorigenin (TEC), and the same adenosine mitogen‐activated protein kinase (MAPK) pathway in both hepatitis and inflammatory bowel disease (IBD) models, exploring the role of TEC in IBD is contributive to develop a new treatment strategy...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Hong Huang, Sanhui Tang, Yanghong Zhou, Yi Cai
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2024-05-01
Schriftenreihe:	Immunity, Inflammation and Disease
Schlagworte:	IBD LPS macrophages MAPK signaling pathway tectorigenin
Online-Zugang:	https://doi.org/10.1002/iid3.1077
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!